vimarsana.com

Latest Breaking News On - Maria tennant - Page 1 : vimarsana.com

LifeArc portfolio company Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics for up to $400 million

First exit for LifeArc Ventures, the largest investor in Ducentis, recognising the transformational potential of its scienceDucentis lead pre-clinical asset DS-234 is being developed for the

LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2

LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2 - read this article along with other careers information, tips and advice on BioSpace

LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2

Mother forced to choose between donating kidney to son or daughter, both suffering from same genetic disorder

» Mother faced having to choose between donating kidney to son or daughter, both suffering from the same genetic disorder Mother faced having to choose between donating kidney to son or daughter, both suffering from the same genetic disorder Naina BhardwajJan 10, 2021, 23:22 IST Sarah, Darryl, Ariel, Casper and Noah Bingham.The Bingham Family A mom was forced to choose between donating her kidney to her son or daughter, who both suffer from the same genetic disorder. Sarah Bingham, 41, of Northumberland, UK, was faced with the decision when her two eldest children, 20-year-old Noah and 16-year-old Ariel, were diagnosed with nephronophthisis. Nephronophthisis is a genetically inherited condition that impairs kidney function through inflammation and scarring.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.